Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings

MRVI·Reported May 12, 2025·After market close

Maravai LifeSciences Holdings, Inc. reported Q1 2025 revenue of $46.9M (-27.0% YoY), beat analyst consensus of $44.0M by $2.8M. Diluted EPS came in at $-0.08 (-300.0% YoY), missed the $-0.07 consensus by $0.01.

Revenue
$46.9Mbeat by $2.8M
Consensus: $44.0M
Diluted EPS
$-0.08missed by $0.01
Consensus: $-0.07
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0001823239-25-000063

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Maravai LifeSciences Holdings, Inc.'s Q1 2025 earnings report.

Maravai LifeSciences Holdings, Inc. (MRVI) reported Q1 2025 earnings on May 12, 2025 after market close.

Maravai LifeSciences Holdings, Inc. reported revenue of $46.9M and diluted EPS of $-0.08 for Q1 2025.

Revenue beat the consensus estimate of $44.0M by $2.8M. EPS missed the consensus estimate of $-0.07 by $0.01.

Compared to the same quarter a year prior, revenue declined 27.0% from $64.2M a year earlier and diluted EPS declined 300.0% from $-0.02.

You can read the 10-Q periodic report (0001823239-25-000063) directly on SEC EDGAR. The filing index links above go to sec.gov.